Bausch Financial Statements From 2010 to 2026

BHC Stock  USD 6.95  0.04  0.57%   
Bausch Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bausch Health's valuation are provided below:
Gross Profit
7.1 B
Profit Margin
0.0361
Market Capitalization
2.6 B
Enterprise Value Revenue
2.2248
Revenue
10 B
We have found one hundred twenty available fundamental signals for Bausch Health Companies, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of Bausch Health's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of January 2, 2026, Market Cap is expected to decline to about 2.5 B. In addition to that, Enterprise Value is expected to decline to about 17.7 B

Bausch Health Total Revenue

11.62 Billion

Check Bausch Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bausch Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 906.4 M, Interest Expense of 1.7 B or Selling General Administrative of 3 B, as well as many indicators such as Price To Sales Ratio of 0.34, Dividend Yield of 0.0534 or Days Sales Outstanding of 95.55. Bausch financial statements analysis is a perfect complement when working with Bausch Health Valuation or Volatility modules.
  
Build AI portfolio with Bausch Stock
Check out the analysis of Bausch Health Correlation against competitors.

Bausch Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15.4 B30.5 B27.2 B
Pretty Stable
Short and Long Term Debt Total26.4 B25.1 B20.6 B
Slightly volatile
Other Current LiabilitiesB3.8 B2.9 B
Slightly volatile
Total Current Liabilities8.2 B7.8 B4.3 B
Slightly volatile
Property Plant And Equipment Net2.1 BB1.3 B
Slightly volatile
Net Debt24.9 B23.7 B19.7 B
Slightly volatile
Accounts Payable792.1 M754.4 M431.6 M
Slightly volatile
Cash1.4 B1.4 B852.5 M
Slightly volatile
Non Current Assets Total13 B23.9 B23.1 B
Pretty Stable
Non Currrent Assets Other241.5 M417.4 M379.7 M
Very volatile
Cash And Short Term Investments1.4 B1.4 B853.1 M
Slightly volatile
Net Receivables2.6 B2.5 B1.8 B
Slightly volatile
Common Stock Shares Outstanding249.9 M423.2 M327.9 M
Slightly volatile
Liabilities And Stockholders Equity15.5 B30.5 B27.5 B
Pretty Stable
Non Current Liabilities Total11.6 B23.1 B21.3 B
Slightly volatile
Other Current AssetsB986.7 M754 M
Slightly volatile
Other Stockholder Equity255.6 M269.1 M291.4 M
Pretty Stable
Total Liabilities32.4 B30.9 B26.3 B
Slightly volatile
Property Plant And Equipment Gross4.7 B4.5 B2.1 B
Slightly volatile
Total Current AssetsB6.6 B4.4 B
Slightly volatile
Short Term Debt3.3 B3.1 B793.8 M
Slightly volatile
Intangible Assets5.8 B6.4 B9.8 B
Pretty Stable
Inventory1.9 B1.8 B1.1 B
Slightly volatile
Common Stock6.1 B12.1 B8.8 B
Slightly volatile
Common Stock Total EquityB11.9 B8.8 B
Slightly volatile
Short Term Investments93 M88.5 M56.4 M
Slightly volatile
Other Liabilities1.3 B1.1 B1.8 B
Very volatile
Long Term Debt14.3 B21.8 B19.3 B
Slightly volatile
Good Will7.4 B12.8 B10.8 B
Slightly volatile
Property Plant Equipment2.4 B2.3 B1.4 B
Slightly volatile
Long Term Debt Total21.6 B21.8 B19.9 B
Slightly volatile
Capital Surpluse262 M210.6 M316.7 M
Pretty Stable
Deferred Long Term Liabilities172.7 M181.8 M1.4 B
Slightly volatile
Long Term Investments5.1 M8.2 M6.8 M
Slightly volatile
Non Current Liabilities Other992.7 M1.2 B923.9 M
Slightly volatile
Deferred Long Term Asset Charges97.8 M167.9 M120.9 M
Slightly volatile
Short and Long Term Debt3.2 B3.1 B778.2 M
Slightly volatile
Cash And Equivalents1.1 B1.4 B872.2 M
Slightly volatile
Net Invested Capital19.4 B18.3 B26.5 B
Slightly volatile
Capital Stock11.3 B12.1 B10.4 B
Slightly volatile

Bausch Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization906.4 M1.5 B1.6 B
Pretty Stable
Selling General AdministrativeB2.9 B1.8 B
Slightly volatile
Total Revenue11.6 B11.1 B7.7 B
Slightly volatile
Gross Profit8.3 B7.9 B5.6 B
Slightly volatile
Other Operating Expenses9.8 B9.3 B7.2 B
Slightly volatile
EBITDA3.8 B3.6 BB
Slightly volatile
Cost Of Revenue3.4 B3.2 B2.1 B
Slightly volatile
Total Operating Expenses6.4 B6.1 B5.1 B
Slightly volatile
Research Development765.6 M729.1 M420.1 M
Slightly volatile
Selling And Marketing Expenses511.2 M903.9 M475.2 M
Slightly volatile
Non Recurring12.8 M13.5 M540.7 M
Slightly volatile
Interest Income28.2 M29.7 M688.7 M
Slightly volatile
Reconciled Depreciation1.5 B1.1 B2.2 B
Slightly volatile
Extraordinary Items780 M877.5 M957.8 M
Slightly volatile

Bausch Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow585 M1.1 B910.7 M
Slightly volatile
Depreciation941.4 M1.5 B1.7 B
Very volatile
Capital Expenditures406.9 M387.6 M290 M
Slightly volatile
End Period Cash Flow1.5 B1.4 BB
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.340.352.1205
Slightly volatile
Dividend Yield0.05340.05790.0609
Pretty Stable
Days Sales Outstanding95.5593.3388.3744
Slightly volatile
Average Payables4.3 MM5.4 M
Slightly volatile
Stock Based Compensation To Revenue0.02090.01790.0151
Very volatile
Capex To Depreciation0.290.310.2225
Pretty Stable
EV To Sales2.682.824.6862
Slightly volatile
Inventory Turnover2.762.012.5072
Slightly volatile
Days Of Inventory On Hand132188168
Pretty Stable
Payables Turnover3.33.824.8435
Very volatile
Sales General And Administrative To Revenue0.290.30.2661
Pretty Stable
Research And Ddevelopement To Revenue0.08980.07580.0585
Slightly volatile
Capex To Revenue0.03830.04030.0431
Slightly volatile
Cash Per Share1.462.892.2579
Pretty Stable
Days Payables Outstanding14798.98107
Slightly volatile
Intangibles To Total Assets0.440.560.6866
Pretty Stable
Net Debt To EBITDA4.135.938.2241
Slightly volatile
Current Ratio1.960.981.2234
Pretty Stable
Receivables Turnover3.684.054.181
Slightly volatile
Capex Per Share0.460.820.7841
Very volatile
Revenue Per Share24.7223.5421.2172
Slightly volatile
Interest Debt Per Share59.6556.8160.4578
Slightly volatile
Debt To Assets0.390.740.707
Pretty Stable
Enterprise Value Over EBITDA8.248.6715.9706
Slightly volatile
Graham Number48.045.7141.5256
Slightly volatile
Operating Cycle198261251
Very volatile
Days Of Payables Outstanding14798.98107
Slightly volatile
Long Term Debt To Capitalization1.010.970.9232
Slightly volatile
Total Debt To Capitalization0.490.960.8925
Very volatile
Cash Ratio0.190.20.2318
Slightly volatile
Days Of Inventory Outstanding132188168
Pretty Stable
Days Of Sales Outstanding95.5593.3388.3744
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.90.910.8456
Pretty Stable
Fixed Asset Turnover3.984.875.4663
Very volatile
Enterprise Value Multiple8.248.6715.9706
Slightly volatile
Debt Ratio0.390.740.707
Pretty Stable
Price Sales Ratio0.340.352.1205
Slightly volatile
Asset Turnover0.430.420.294
Slightly volatile
Gross Profit Margin0.810.820.7396
Very volatile

Bausch Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.5 B2.6 B11.4 B
Slightly volatile
Enterprise Value17.7 B21.9 B30.2 B
Pretty Stable

Bausch Fundamental Market Drivers

Forward Price Earnings1.6236
Cash And Short Term Investments1.2 B

Bausch Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bausch Health Financial Statements

Bausch Health stakeholders use historical fundamental indicators, such as Bausch Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bausch Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bausch Health's assets and liabilities are reflected in the revenues and expenses on Bausch Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bausch Health Companies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.4 B2.5 B
Total Revenue11.1 B11.6 B
Cost Of Revenue3.2 B3.4 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.29 
Research And Ddevelopement To Revenue 0.08  0.09 
Capex To Revenue 0.04  0.04 
Revenue Per Share 23.54  24.72 
Ebit Per Revenue 0.16  0.18 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out the analysis of Bausch Health Correlation against competitors.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
13.68
Earnings Share
0.97
Revenue Per Share
26.902
Quarterly Revenue Growth
0.068
Return On Assets
0.0483
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.